Terms of Service · Privacy Policy · Disclaimer
By using this site you agree to our Terms of Service and Disclaimer.
PMHNP Helper
Practice QuestionsCase Library
MedicationsDiagnosesDifferentials
FlashcardsStudy Plan
PricingAbout
Practice QuestionsCase LibraryMedicationsDiagnosesDifferentialsFlashcardsStudy PlanPricingAbout
Questions/Scientific Foundation/Q35 of 51
intermediatehistamineH1 receptor5-HT2Colanzapineweight gainsedationtuberomammillary nucleusmetabolic effects
A 34-year-old woman with bipolar II disorder stabilized on olanzapine 10 mg nightly has gained 30 pounds over 6 months. She also reports excessive daytime sedation despite adequate sleep. Her PMHNP reviews the receptor binding profile of olanzapine to identify which pharmacological actions are driving these side effects. Which of the following best explains the neurobiological basis of olanzapine's sedation and weight gain?
← PreviousAll Scientific FoundationNext →